Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Mammalia
Entry Details
ID
364
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q8IWK6 (Created: 2004-07-19 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name
GP125_HUMAN
Protein Name
Probable G-protein coupled receptor 125
Gene
GPR125
Organism Scientific
Homo sapiens
Organism Common
Human
Lineage
Eukaryota
Metazoa
Chordata
Craniata
Vertebrata
Euteleostomi
Mammalia
Eutheria
Euarchontoglires
Primates
Haplorrhini
Catarrhini
Hominidae
Homo
Protein Length [aa]
1321
Protein Mass [Da]
146151
Features
Type
Description
Status
Start
End
signal peptide
potential
1
33
chain
Probable G-protein coupled receptor 125
34
1321
transmembrane region
1
potential
762
782
transmembrane region
2
potential
797
817
transmembrane region
3
potential
827
847
transmembrane region
4
potential
877
897
transmembrane region
5
potential
920
940
transmembrane region
6
potential
997
1017
transmembrane region
7
potential
1025
1045
topological domain
Extracellular
potential
34
761
topological domain
Cytoplasmic
potential
783
796
topological domain
Extracellular
potential
818
826
topological domain
Cytoplasmic
potential
848
876
topological domain
Extracellular
potential
898
919
topological domain
Cytoplasmic
potential
941
996
topological domain
Extracellular
potential
1018
1024
topological domain
Cytoplasmic
potential
1046
1321
domain
Ig-like
242
340
domain
GPS
698
749
modified residue
Phosphothreonine
208
208
glycosylation site
N-linked (GlcNAc...)
potential
81
81
glycosylation site
N-linked (GlcNAc...)
potential
98
98
glycosylation site
N-linked (GlcNAc...)
potential
159
159
glycosylation site
N-linked (GlcNAc...)
potential
206
206
glycosylation site
N-linked (GlcNAc...)
potential
301
301
glycosylation site
N-linked (GlcNAc...)
potential
332
332
glycosylation site
N-linked (GlcNAc...)
potential
433
433
glycosylation site
N-linked (GlcNAc...)
potential
453
453
glycosylation site
N-linked (GlcNAc...)
potential
592
592
glycosylation site
N-linked (GlcNAc...)
potential
652
652
glycosylation site
N-linked (GlcNAc...)
potential
687
687
glycosylation site
N-linked (GlcNAc...)
potential
728
728
glycosylation site
N-linked (GlcNAc...)
potential
821
821
sequence variant
(in dbSNP:rs9002)
0
0
sequence variant
(in dbSNP:rs3814416)
0
0
repeat
LRR 1
79
103
repeat
LRR 2
104
127
repeat
LRR 3
128
151
repeat
LRR 4
153
175
repeat
LRR 5
594
620
splice variant
(in isoform 4)
0
0
splice variant
(in isoform 2)
0
0
splice variant
(in isoform 4)
0
0
splice variant
(in isoform 3)
0
0
splice variant
(in isoform 4)
11
236
splice variant
(in isoform 3)
603
620
splice variant
(in isoform 4)
608
1321
splice variant
(in isoform 2)
617
1321
short sequence motif
PDZ-binding
potential
1319
1321
SP Length
33
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGG
Sequence
MEPPGRRRGR
AQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPR
GAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGS
FSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFR
GLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHR
WVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCD
PPLEL
PSFYMTPSH
RQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH
N
CSLIASALTISNIQAGSTGNWGCHVQTKRG
N
NTRTVDIV
VLESSAQYCP
PERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRC
DRGGFWADDDYSRCQYANDVTRVLYMFNQMPL
N
LTNAVATARQLLAYTVE
AA
N
FSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERV
LWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKST
GFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKC
N
V
SNTFSSL
AL
KNTIV
EASIQLPPS
LFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPAT
GNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAV
AARWDFDLLNGQGGWKSDGCHILYSDENITTIQCYSLSNYAVLMDLTGSE
LYTQAASLLHPVVYTTAIILLLCLLAVIVSYIYHHSLIRISLKSWHMLVN
LCFHIFLTCVVFVGGITQTRNASICQAVGIILHYSTLATVLWVGVTARNI
YKQVTKKAKRCQDPDEPPPPPRPMLRFYLIGGGIPIIVCGITAAANIKNY
GSRPNAPYCWMAWEPSLGAFYGPASFITFVNCMYFLSIFIQLKRHPERKY
ELKEPTEEQQRLAANENGEINHQDSMSLSLISTSALENEHTFHSQLLGAS
LTLLLYVALWMFGALAVSLYYPLDLVFSFVFGATSLSFSAFFVVHHCVNR
EDVRLAWIMTCCPGRSSYSVQVNVQPPNSNGTNGEAPKCPNSSAESSCTN
KSASSFKNSSQGCKLTNLQAAAAQCHANSLPLNSTPQLDNSLTEHSMDND
IKMHVAPLEVQFRTNVHSSRHHKNRSKGHRASRLTVLREYAYDVPTSVEG
SVQNGLPKSRLGNNEGHSRSRRAYLAYRERQYNPPQQDSSDACSTLPKSS
RNFEKPVSTTSKKDALRKPAVVELENQQKSYGLNLAIQNGPIKSNGQEGP
LLGTDSTGNVRTGLWKHE
TTV
Original
MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPR
GAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGS
FSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFR
GLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHR
WVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSH
RQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIH
NCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCP
PERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRC
DRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLLAYTVE
AANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERV
LWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKST
GFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSL
ALKNTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPAT
GNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAV
AARWDFDLLNGQGGWKSDGCHILYSDENITTIQCYSLSNYAVLMDLTGSE
LYTQAASLLHPVVYTTAIILLLCLLAVIVSYIYHHSLIRISLKSWHMLVN
LCFHIFLTCVVFVGGITQTRNASICQAVGIILHYSTLATVLWVGVTARNI
YKQVTKKAKRCQDPDEPPPPPRPMLRFYLIGGGIPIIVCGITAAANIKNY
GSRPNAPYCWMAWEPSLGAFYGPASFITFVNCMYFLSIFIQLKRHPERKY
ELKEPTEEQQRLAANENGEINHQDSMSLSLISTSALENEHTFHSQLLGAS
LTLLLYVALWMFGALAVSLYYPLDLVFSFVFGATSLSFSAFFVVHHCVNR
EDVRLAWIMTCCPGRSSYSVQVNVQPPNSNGTNGEAPKCPNSSAESSCTN
KSASSFKNSSQGCKLTNLQAAAAQCHANSLPLNSTPQLDNSLTEHSMDND
IKMHVAPLEVQFRTNVHSSRHHKNRSKGHRASRLTVLREYAYDVPTSVEG
SVQNGLPKSRLGNNEGHSRSRRAYLAYRERQYNPPQQDSSDACSTLPKSS
RNFEKPVSTTSKKDALRKPAVVELENQQKSYGLNLAIQNGPIKSNGQEGP
LLGTDSTGNVRTGLWKHETTV
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11